Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000671255 | SCV000796212 | likely pathogenic | Usher syndrome type 2A; Retinitis pigmentosa 39 | 2017-12-05 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002532108 | SCV003310535 | pathogenic | not provided | 2022-08-05 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg5108Glyfs*6) in the USH2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Usher syndrome (PMID: 25575603). ClinVar contains an entry for this variant (Variation ID: 555433). For these reasons, this variant has been classified as Pathogenic. |
Genome- |
RCV003453323 | SCV004183247 | likely pathogenic | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003453322 | SCV004183258 | likely pathogenic | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing |